SCHEMBL23584612

SCHEMBL23584612

CC(C)(C)OC(=O)NC1CCCN(CC2CCC(n3ccc4c(N)ncnc43)O2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 2/20 0.47
▸ PRMT5 O14744 4/20 0.42
▸ WDR77 Q9BQA1 3/20 0.42
▸ AURKA O14965 3/20 0.38
▸ PDPK1 O15530 3/20 0.38
▸ AURKB Q96GD4 3/20 0.38
▸ JAK2 O60674 3/20 0.38
▸ JAK1 P23458 3/20 0.38
▸ JAK3 P52333 2/20 0.37
▸ RET P07949 2/20 0.36
▸ KDR P35968 1/20 0.36
▸ PTK6 Q13882 3/20 0.36
▸ ABL1 P00519 2/20 0.36
▸ SRC P12931 2/20 0.36
▸ METTL3 Q86U44 1/20 0.36
▸ LCK P06239 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ LYN P07948 1/20 0.36
▸ HCK P08631 1/20 0.36
▸ FRK P42685 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23584729 0.88 PRMT5 (0.38) MAP4K4PRMT5WDR77JAK2JAK1
SCHEMBL23584552 0.83 PRMT5 (0.38) MAP4K4PRMT5WDR77PTK6SRC
SCHEMBL22434971 0.83 SIRT2 (0.41) PRMT5WDR77JAK2JAK1PTK6
SCHEMBL19344003 0.82 MAP4K4 (0.43) MAP4K4PRMT5WDR77METTL3
SCHEMBL22435004 0.82 PRMT5 (0.37) PRMT5WDR77JAK2JAK1PTK6
SCHEMBL22435002 0.80 PRMT5 (0.38) MAP4K4PRMT5WDR77METTL3
SCHEMBL23584841 0.79 MEN1 (0.42) PRMT5WDR77METTL3
SCHEMBL23584475 0.79 PRMT5 (0.40) PRMT5WDR77ABL1SRCMETTL3
SCHEMBL23584745 0.79 PRMT5 (0.40) PRMT5WDR77ABL1SRCMETTL3
SCHEMBL23584567 0.79 DRD2 (0.38) PRMT5JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback